Literature DB >> 7862377

Plasma cell endometritis in women with symptomatic bacterial vaginosis.

A P Korn1, G Bolan, N Padian, M Ohm-Smith, J Schachter, D V Landers.   

Abstract

OBJECTIVE: To evaluate the endometrial microbiology and histopathology in women with symptomatic bacterial vaginosis but no signs or symptoms of upper genital tract disease or other vaginal or cervical infections.
METHODS: Endometrial biopsies were performed on 41 women complaining of vaginal discharge or pelvic pain at a sexually transmitted disease clinic. These women had neither culture nor serologic evidence of Neisseria gonorrhoeae or Chlamydia trachomatis infection. Twenty-two women with bacterial vaginosis diagnosed by Gram stain examination of vaginal fluid, but with neither signs nor symptoms of upper genital tract infection, were compared with 19 women who had no evidence of bacterial vaginosis on vaginal fluid Gram stain. Endometrial biopsies were evaluated for histopathologic evidence of plasma cell endometritis and were cultured for N gonorrhoeae, C trachomatis, aerobic and anaerobic bacteria, Mycoplasma species, and Ureaplasma urealyticum.
RESULTS: Ten of 22 women with bacterial vaginosis had plasma cell endometritis, compared with one of 19 controls (odds ratio [OR] 15, 95% confidence interval [CI] 2-686; P < .01). Bacterial vaginosis-associated organisms were cultured from the endometria of nine of 11 women with and eight of 30 women without plasma cell endometritis (OR 12.4, 95% CI 2-132; P = .002).
CONCLUSION: Plasma cell endometritis was frequently present in women with bacterial vaginosis and without other vaginal or cervical infections. This suggests the possibility of an association between bacterial vaginosis and nonchlamydial, nongonococcal, upper genital tract infection.

Entities:  

Mesh:

Year:  1995        PMID: 7862377     DOI: 10.1016/0029-7844(94)00400-8

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  29 in total

1.  Why common things are common: the tale of non-gonococcal urethritis.

Authors:  M Shahmanesh
Journal:  Sex Transm Infect       Date:  2001-04       Impact factor: 3.519

2.  Risk and prevalence of treatable sexually transmitted diseases at a Birmingham substance abuse treatment facility.

Authors:  L H Bachmann; I Lewis; R Allen; J R Schwebke; L C Leviton; H A Siegal; E W Hook
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

3.  Gynecologic Complications of Bacterial Vaginosis: Fact or Fiction?

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

4.  Bacterial Vaginosis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

5.  Recurrent Bacterial Vaginosis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-12       Impact factor: 3.725

6.  Pelvic Inflammatory Disease: Current Concepts of Diagnosis and Management.

Authors:  Richard L Sweet
Journal:  Curr Infect Dis Rep       Date:  2012-02-02       Impact factor: 3.725

7.  Findings associated with recurrence of bacterial vaginosis among adolescents attending sexually transmitted diseases clinics.

Authors:  Rebecca M Brotman; Emily J Erbelding; Roxanne M Jamshidi; Mark A Klebanoff; Jonathan M Zenilman; Khalil G Ghanem
Journal:  J Pediatr Adolesc Gynecol       Date:  2007-08       Impact factor: 1.814

8.  Male reproductive proteins and reproductive outcomes.

Authors:  Roberta B Ness; David A Grainger
Journal:  Am J Obstet Gynecol       Date:  2008-01-14       Impact factor: 8.661

9.  Chronic endometritis due to common bacteria is prevalent in women with recurrent miscarriage as confirmed by improved pregnancy outcome after antibiotic treatment.

Authors:  Ettore Cicinelli; Maria Matteo; Raffaele Tinelli; Vincenzo Pinto; Marco Marinaccio; Ugo Indraccolo; Dominique De Ziegler; Leonardo Resta
Journal:  Reprod Sci       Date:  2013-10-31       Impact factor: 3.060

10.  The laboratory diagnosis of bacterial vaginosis.

Authors:  Deborah Money
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-03       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.